These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6976466)

  • 1. [A case of primary B-cell origin lymphoma of the stomach seen during diphenylhydantoin therapy (author's transl)].
    Matoba K; Katsumata T; Kakei M; Kuwata H; Nakazawa H; Saigeni K; Okabe H; Chin S; Maekawa K; Katsuoka K; Oh-Ida M; Atari H
    Nihon Shokakibyo Gakkai Zasshi; 1981 Sep; 78(9):1797-802. PubMed ID: 6976466
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of diphenylhydantoin-induced pseudo-pseudolymphoma (author's transl)].
    Matsuo T; Matsumoto A; Miyasaki K
    Nihon Naika Gakkai Zasshi; 1977 Mar; 66(3):317-21. PubMed ID: 559053
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Immunoblactic lymphadenopathy associated with phenytoin (diphenylhydantoin).
    Lapes MJ; Vivacqua RJ; Antoniades K
    Lancet; 1976 Jan; 1(7952):198. PubMed ID: 54713
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant lymphoma after diphenylhydantoin (dilantin) therapy.
    Li FP; Willard DR; Goodman R; Vawter G
    Cancer; 1975 Oct; 36(4):1359-62. PubMed ID: 1175133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3 cases of malignant lymphoma or pseudolymphoma in epileptics treated with diphenylhydantoin].
    Alberto P; Cougn R; Maurice P; Weber J
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1773-4. PubMed ID: 5140914
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudolymphoma induced by diphenylhydantoin.
    Gams RA
    J Pediatr; 1970 Dec; 77(6):1100-1. PubMed ID: 5486632
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of diphenylhydantoin induced lymphadenopathy (author's transl)].
    Ashizawa T; Oda E; Sakuragawa N; Shibata A; Sekiya M; Nemoto K; Okamura A; Ohnishi Y
    Rinsho Ketsueki; 1979 Apr; 20(4):393-9. PubMed ID: 449058
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudolymphoma induced by diphenylhydantoin.
    Choovivathanavanich P; Wallace EM; Scaglione PR
    J Pediatr; 1970 Apr; 76(4):621-3. PubMed ID: 5420803
    [No Abstract]   [Full Text] [Related]  

  • 9. [Permanent cerebellar degeneration secondary to diphenylhydantoin (author's transl)].
    Rosich Pla A
    Med Clin (Barc); 1980 Nov; 75(9):387-90. PubMed ID: 7464334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Macrocytic anemia due to folic acid deficiency and non-Hodgkin's lymphoma associated with prolonged diphenylhydantoin ingestion].
    Pereira A; Cervantes F; Rozman C
    Med Clin (Barc); 1985 Oct; 85(12):503-5. PubMed ID: 4079508
    [No Abstract]   [Full Text] [Related]  

  • 11. [Case of "exanthematous pseudolymphoma" due to diphenylhydantoin hypersensitivity with a transitory immunologic deficit].
    Vellucci A; Galanti G; Pezzella B; De Longis P; Colacecchi C
    Clin Ter; 1980 Jul; 94(2):229-37. PubMed ID: 7449346
    [No Abstract]   [Full Text] [Related]  

  • 12. An unusual dual hypersensitivity reaction induced by diphenylhydantoin.
    Sisca TS
    Am J Hosp Pharm; 1973 May; 30(5):446-9. PubMed ID: 4267436
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudolymphoma with mycosis fungoides manifestations, hyperresponsiveness to diphenylhydantoin, and lymphocyte disregulation.
    Rosenthal CJ; Noguera CA; Coppola A; Kapelner SN
    Cancer; 1982 Jun; 49(11):2305-14. PubMed ID: 6978761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic and immunologic aberrations in patients under diphenylhydantoin administration.
    Isobe T; Tomita M; Matsumoto J; Itoh T; Fujita T
    Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):1-5. PubMed ID: 6858559
    [No Abstract]   [Full Text] [Related]  

  • 15. [5 cases showing hemoglobinuria and aplastic crisis following administration of diphenylhydantoin after craniotomy (author's transl)].
    Hotta T; Hirabayashi N; Kobayashi T; Nakamura S; Suzuki Y
    Rinsho Ketsueki; 1980 Apr; 21(4):536-43. PubMed ID: 7411883
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pseudomononucleosis induced by diphenylhydantoin (author's transl)].
    Rodriguez Jornet A; Matías-Guiu J; Coll de Tuero G; Villegas Sánchez G; Sánchez Novials A; Sabriá Leal M
    Med Clin (Barc); 1981 Oct; 77(6):250-2. PubMed ID: 7321640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized cutaneous pseudolymphoma associated with phenytoin therapy: a case report.
    Adams JD
    Australas J Dermatol; 1981 Apr; 22(1):28-9. PubMed ID: 7259668
    [No Abstract]   [Full Text] [Related]  

  • 18. Is phenytoin carcinogenic?
    Kruger GR; Harris D
    Lancet; 1972 Feb; 1(7745):323. PubMed ID: 4109962
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lymphadenopathy in phenytoin treatment (author's transl)].
    Seyfeddinipur N
    Dtsch Med Wochenschr; 1976 Oct; 101(40):1454-6. PubMed ID: 823005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant-induced lymphoma.
    Fried MP; Sunwoo Y
    Laryngoscope; 1975 Oct; 85(10):1770-81. PubMed ID: 1186408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.